Bradykinin-induced blood-tumor barrier opening is mediated by tumor necrosis factor-α

被引:17
|
作者
Juan, Qin Li [2 ]
Yan-Ting, Gu [3 ]
Hua, Zhang [1 ]
Yi-Xue, Xue [1 ]
机构
[1] China Med Univ, Dept Neurobiol, Coll Basic Med Sci, Shenyang 110001, Liaoning Prov, Peoples R China
[2] Inner Mongolia Med Coll, Coll Basic Med Sci, Dept Physiol, Hohhot 010059, Inner Mongolia, Peoples R China
[3] Shenyang Pharmaceut Univ, Life Sci & Biol Pharmacopedia Inst, Dept Physiol, Shenyang 110001, Liaoning Prov, Peoples R China
关键词
Tumor necrosis factor-alpha; Heat shock factor-1; Bradykinin; Blood-tumor barrier; ENDOTHELIAL-CELL MONOLAYERS; EXPERIMENTAL BRAIN-TUMORS; POTASSIUM CHANNEL; PERMEABILITY; EXPRESSION; INTERLEUKIN-1-BETA; INHIBITION; INTERFERON; ASTROCYTES; DELIVERY;
D O I
10.1016/j.neulet.2008.10.080
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Bradykinin has been shown to increase the permeability of blood-tumor barrier (BTB) selectively. This study was performed to determine whether tumor necrosis factor-alpha (TNF-alpha) was involved in the regulation of this biological process. We found that the levels of TNF-alpha mRNA and heat shock factor-1 (HSF1) protein in C6 cells were markedly up-regulated by bradykinin via real-time RT-PCR and Western blot methods. And the most obvious increase of HSF1 protein and TNF-alpha mRNA in C6 cells were observed at 5 min and 10 min of bradykinin perfusion, respectively. In addition, the radioactivity of TNF-alpha in C6 cells' culture fluid also mostly increased at 15 min of bradykinin perfusion. And the Evans blue content of brain tumor tissues in rats and the concentration of TNF-alpha reached the maximum at 15 min of bradykinin perfusion. Our results suggested that the bradykinin-mediated BTB permeability increase is due to accelerated release of TNF-a, which could cause the increase of BTB permeability by promoting to the release HSF1 from neurospongioma cells. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:172 / 175
页数:4
相关论文
共 50 条
  • [21] Tumor Necrosis Factor-α Blocker Induced Tuberculosis
    Kharbanda, Priyanka
    Dagaonkar, Rucha
    Balakrishnan, Canchi
    Udwadia, Zarir F.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1542 - 1543
  • [22] Role of tumor necrosis factor-α in Mycobacterium-induced granuloma formation in tumor necrosis factor-α-deficient mice
    Kaneko, H
    Yamada, H
    Mizuno, S
    Udagawa, T
    Kazumi, Y
    Sekikawa, K
    Sugawara, I
    LABORATORY INVESTIGATION, 1999, 79 (04) : 379 - 386
  • [23] Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel
    Zhang, Hua
    Gu, Yan Ting
    Xue, Yi Xue
    BRAIN RESEARCH, 2007, 1144 : 33 - 41
  • [24] Tumor necrosis factor-α increases lactoferrin transcytosis through the blood-brain barrier
    Fillebeen, C
    Dehouck, B
    Benaïssa, M
    Dhennin-Duthille, I
    Cecchelli, R
    Pierce, A
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) : 2491 - 2500
  • [25] BLOOD-TUMOR BARRIER DISRUPTION CONTROVERSIES - REPLY
    RAPOPORT, SI
    ROBINSON, PJ
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (01): : 166 - 168
  • [26] SELECTIVE BLOOD-TUMOR BARRIER DISRUPTION BY LEUKOTRIENES
    CHIO, CC
    BABA, T
    BLACK, KL
    JOURNAL OF NEUROSURGERY, 1992, 77 (03) : 407 - 410
  • [27] Modulation of the "blood-tumor" barrier improves immunotherapy
    Manzur, Mitali
    Hamzah, Juliana
    Ganss, Ruth
    CELL CYCLE, 2008, 7 (16) : 2452 - 2455
  • [28] Focused ultrasound induced blood-tumor barrier permeability of combinatorial chemotherapy
    Arsiwala, Tasneem A.
    Blethen, Kathryn E.
    Sprowls, Samuel A.
    Fladeland, Ross A.
    Keilkowski, Brooke
    Glass, Morgan
    Pritt, Trenton
    Wang, Peng
    Reza, Ali, I
    Lockman, Paul R.
    CANCER RESEARCH, 2022, 82 (12)
  • [29] SELECTIVE OPENING OF THE BLOOD-TUMOR BARRIER BY INTRACAROTID INFUSION OF LEUKOTRIENE-C4
    BLACK, KL
    KING, WA
    IKEZAKI, K
    CONKLIN, S
    BECKER, DP
    JOURNAL OF NEUROSURGERY, 1990, 72 (02) : A348 - A348
  • [30] Tumor necrosis factor-α-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy
    Satoh, M
    Nakamura, M
    Saitoh, H
    Satoh, H
    Maesawa, C
    Segawa, N
    Tashiro, A
    Hiramori, K
    CIRCULATION, 1999, 99 (25) : 3260 - 3265